1. Home
  2. SPB vs COAG Comparison

SPB vs COAG Comparison

Compare SPB & COAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectrum Brands Holdings Inc.

SPB

Spectrum Brands Holdings Inc.

HOLD

Current Price

$88.35

Market Cap

2.0B

Sector

Miscellaneous

ML Signal

HOLD

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$38.33

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPB
COAG
Founded
1906
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
SPB
COAG
Price
$88.35
$38.33
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$82.40
N/A
AVG Volume (30 Days)
235.9K
366.5K
Earning Date
05-07-2026
N/A
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
1.01
N/A
Revenue
$3,802,100,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$1.85
N/A
P/E Ratio
$84.38
N/A
Revenue Growth
20.86
N/A
52 Week Low
$49.99
$27.47
52 Week High
$99.06
$55.42

Technical Indicators

Market Signals
Indicator
SPB
COAG
Relative Strength Index (RSI) 50.34 35.66
Support Level $85.13 $29.54
Resistance Level $89.53 $38.87
Average True Range (ATR) 1.93 3.04
MACD -0.05 -0.48
Stochastic Oscillator 52.48 13.71

Price Performance

Historical Comparison
SPB
COAG

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Share on Social Networks: